IL145546D0 - Disodium salts, monohydrates, and ethanol solvates for delivering active agents - Google Patents

Disodium salts, monohydrates, and ethanol solvates for delivering active agents

Info

Publication number
IL145546D0
IL145546D0 IL14554600A IL14554600A IL145546D0 IL 145546 D0 IL145546 D0 IL 145546D0 IL 14554600 A IL14554600 A IL 14554600A IL 14554600 A IL14554600 A IL 14554600A IL 145546 D0 IL145546 D0 IL 145546D0
Authority
IL
Israel
Prior art keywords
monohydrates
active agents
delivering active
disodium salts
ethanol solvates
Prior art date
Application number
IL14554600A
Original Assignee
Emisphere Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US12775499P priority Critical
Priority to US18614300P priority
Priority to US18614200P priority
Priority to US19128600P priority
Application filed by Emisphere Tech Inc filed Critical Emisphere Tech Inc
Priority to PCT/US2000/009390 priority patent/WO2000059863A1/en
Publication of IL145546D0 publication Critical patent/IL145546D0/en

Links

IL14554600A 1999-04-05 2000-04-05 Disodium salts, monohydrates, and ethanol solvates for delivering active agents IL145546D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US12775499P true 1999-04-05 1999-04-05
US18614300P true 2000-03-01 2000-03-01
US18614200P true 2000-03-01 2000-03-01
US19128600P true 2000-03-21 2000-03-21
PCT/US2000/009390 WO2000059863A1 (en) 1999-04-05 2000-04-05 Disodium salts, monohydrates, and ethanol solvates

Publications (1)

Publication Number Publication Date
IL145546D0 true IL145546D0 (en) 2002-06-30

Family

ID=27494697

Family Applications (4)

Application Number Title Priority Date Filing Date
IL14554600A IL145546D0 (en) 1999-04-05 2000-04-05 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
IL14554601A IL145546A (en) 1999-04-05 2001-09-21 Disodium salts, monohydrates and ethanol solvates for delivering active agents
IL16615805A IL166158A (en) 1999-04-05 2005-01-05 Disodium salts, monohydrates and ethanol solvates for delivering active agents
IL18011806A IL180118A (en) 1999-04-05 2006-12-17 Disodium salts, monohydrates and ethanol solvates for delivering active agents

Family Applications After (3)

Application Number Title Priority Date Filing Date
IL14554601A IL145546A (en) 1999-04-05 2001-09-21 Disodium salts, monohydrates and ethanol solvates for delivering active agents
IL16615805A IL166158A (en) 1999-04-05 2005-01-05 Disodium salts, monohydrates and ethanol solvates for delivering active agents
IL18011806A IL180118A (en) 1999-04-05 2006-12-17 Disodium salts, monohydrates and ethanol solvates for delivering active agents

Country Status (12)

Country Link
US (6) US20020065255A1 (en)
EP (1) EP1175390B1 (en)
JP (2) JP4588221B2 (en)
AT (1) AT288415T (en)
AU (1) AU4216700A (en)
CA (1) CA2369591C (en)
DE (1) DE60017888T2 (en)
ES (1) ES2235854T3 (en)
HK (1) HK1045680A1 (en)
IL (4) IL145546D0 (en)
NZ (1) NZ534409A (en)
WO (1) WO2000059863A1 (en)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461643B2 (en) 1993-04-22 2002-10-08 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
SI9720025A (en) 1996-03-29 1999-08-31 Emishphere Technologies, Inc. Compounds and compositions for delivering active agents
US6440929B1 (en) 1998-07-27 2002-08-27 Emisphere Technologies, Inc. Pulmonary delivery of active agents
TR200100922T2 (en) 1998-07-27 2001-09-21 Emisphere Technologies Inc. applying the lungs by way of the active ingredient.
DE60017888T2 (en) * 1999-04-05 2006-01-19 Emisphere Technologies, Inc. Dinatrium salts, monohydrate and ethanol solvate
US7151191B2 (en) * 2000-01-13 2006-12-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US7049283B2 (en) 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
ES2282436T3 (en) * 2001-06-01 2007-10-16 Novartis Ag Oral administration of partiroid hormone and calcitonine.
HU0401441A3 (en) * 2001-08-17 2012-09-28 Novartis Ag 5-cnac as oral delivery agent for parathyroid hormone fragments
US20040259952A1 (en) 2001-11-29 2004-12-23 Richat Abbas Formulations for oral administration of cromolyn sodium
AU2003223158B2 (en) 2002-01-09 2008-01-17 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
PL209734B1 (en) 2002-02-20 2011-10-31 Emisphere Technologies, Inc. Method for administering glp-1 molecules
US20050054557A1 (en) * 2002-05-09 2005-03-10 Goldberg Michael M. Compositions for delivering parathyroid hormone and calcitonin
TW200403052A (en) * 2002-07-17 2004-03-01 Novartis Ag Use of organic compounds
AR040737A1 (en) * 2002-08-01 2005-04-20 Novartis Ag Oral administration of calcitonin
US20070065505A1 (en) 2003-07-11 2007-03-22 Shoufeng Li Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form
JP4716987B2 (en) 2003-07-23 2011-07-06 ノバルティス アーゲー Use of calcitonin in osteoarthritis
US7318925B2 (en) * 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
AU2004267044B8 (en) 2003-08-20 2009-12-17 Emisphere Technologies, Inc. Compounds, methods and formulations for the oral delivery of a glucagon like peptide (GLP)-1 compound or an melanocortin 4 receptor (MC4) agonist peptide
CA2532026C (en) 2003-08-20 2012-04-17 Eli Lilly And Company Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
US20060286129A1 (en) 2003-12-19 2006-12-21 Emisphere Technologies, Inc. Oral GLP-1 formulations
US7217703B2 (en) 2004-04-16 2007-05-15 Emisphere Technologies, Inc. 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
CN102001962B (en) 2004-05-06 2013-04-03 爱密斯菲尔科技公司 Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate
CA2564866A1 (en) 2004-05-06 2005-11-17 Emisphere Technologies, Inc. Solid dosage form of wetted heparin
CN1953753B (en) 2004-05-06 2011-02-09 爱密斯菲尔科技公司 Crystalline polymorphic forms of monosodium N-[8-(2-hydroxybenzoyl)amino]caprylate
KR101193228B1 (en) * 2004-05-06 2012-10-22 에미스페어 테크놀로지스, 인코포레이티드 Crystalline polymorphine forms of monosodium n-[8-2-hydroxybenzoylamino]caprylate
EP2279732B1 (en) 2004-05-14 2019-03-20 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
RU2530889C2 (en) * 2004-05-14 2014-10-20 Эмисфире Текнолоджис, Инк. Compounds and formulations for active substance delivery
CA2566161C (en) 2004-05-14 2013-10-01 Emisphere Technologies, Inc. Aryl ketone compounds and compositions for delivering active agents
NZ551597A (en) * 2004-05-19 2010-11-26 Emisphere Tech Inc Topical cromolyn formulations
WO2005112937A1 (en) * 2004-05-19 2005-12-01 Emisphere Technologies, Inc. Acyclovir formulations
JP5749879B2 (en) * 2004-07-12 2015-07-15 エミスフェアー・テクノロジーズ・インク Composition for delivery of peptide YY and peptide YY agonist
US20100048454A1 (en) 2004-08-03 2010-02-25 Emisphere Technologies, Inc. Antidiabetic oral insulin-biguanide combination
GB0422644D0 (en) * 2004-10-12 2004-11-10 Novartis Ag Organic compounds
GB0427600D0 (en) * 2004-12-16 2005-01-19 Novartis Ag Organic compounds
GB0427603D0 (en) * 2004-12-16 2005-01-19 Novartis Ag Organic compounds
CA2591515C (en) * 2004-12-29 2010-06-22 Emisphere Technologies, Inc. Pharmaceutical formulations of gallium salts
WO2006076692A1 (en) * 2005-01-12 2006-07-20 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
WO2007005995A2 (en) * 2005-07-05 2007-01-11 Emisphere Technologies, Inc. Compositions for buccal delivery of human growth hormone
US20070049557A1 (en) 2005-08-24 2007-03-01 Hashim Ahmed Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers
PE20070548A1 (en) * 2005-09-19 2007-07-12 Emisphere Tech Inc crystal forms of the di-sodium salt of the N- (5-chlorosalicyloyl) -8-aminocaprylic
GB0522566D0 (en) 2005-11-04 2005-12-14 Novartis Ag Organic compounds
RU2469709C2 (en) 2005-11-17 2012-12-20 Новартис Аг Pharmaceutical composition
US20070232537A1 (en) * 2005-12-19 2007-10-04 Nastech Pharmaceutical Company Inc. Intranasal pyy formulations with improved transmucosal pharmacokinetics
WO2007121318A2 (en) 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin
WO2007133944A2 (en) 2006-05-09 2007-11-22 Emisphere Technologies, Inc. Topical administration of acyclovir
EP2040718B1 (en) * 2006-06-28 2017-12-27 Emisphere Technologies, Inc. Gallium nitrate formulations
CA2659655A1 (en) 2006-08-08 2008-02-21 Alan M. Fogelman Salicylanilides enhance oral delivery of therapeutic peptides
EP2057112B1 (en) * 2006-08-31 2018-12-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
CA2661521C (en) 2006-08-31 2016-04-12 Novartis Ag Pharmaceutical compositions comprising hgh for oral delivery
CN101506147B (en) * 2006-09-07 2012-03-21 意米斯菲尔技术公司 A process for the manufacture of snac (n-(8-[2-hydroxybenzoyl]-amino) salcaprozate sodium)
CA2679782C (en) * 2007-03-02 2015-02-17 Novartis Ag Oral administration of a calcitonin
EP2134351B1 (en) 2007-03-13 2016-04-27 Nutrition 21, Inc. Methods and compositions for the sustained release of chromium
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
US20110092426A1 (en) 2007-08-09 2011-04-21 Novartis Ag Oral calcitonin compositions and applications thereof
MX2010004716A (en) * 2007-11-02 2010-12-17 Emisphere Tech Inc Method of treating vitamin b12 deficiency.
EP2331522B1 (en) * 2008-08-01 2013-09-18 Purdue Pharma LP Tetrahydropyridinyl and dihydropyrrolyl compounds and the use thereof
CA2751612A1 (en) 2009-02-06 2010-08-12 The Regents Of The University Of California Calcium-binding agents induce hair growth and/or nail growth
US20120046224A1 (en) * 2009-03-12 2012-02-23 Nordic Bioscience A/S Treatment of diabetes and metabolic syndrome
WO2011017346A2 (en) 2009-08-03 2011-02-10 Emisphere Technologies, Inc. Fast-acting naproxen composition with reduced gastrointestinal effects
MX2012009914A (en) * 2010-02-24 2013-03-05 Emisphere Tech Inc Oral b12 therapy.
CA2802184C (en) * 2010-06-09 2019-01-08 Emisphere Technologies, Inc. Oral iron deficiency therapy
ES2705027T3 (en) 2010-08-19 2019-03-21 Buck Institute For Age Res Methods of treatment of mild cognitive impairment (MCI) and related disorders
EP2609114B1 (en) 2010-08-24 2018-04-11 Abbott Laboratories Hiv core protein specific antibodies and uses thereof
WO2012094381A2 (en) 2011-01-05 2012-07-12 Hospira, Inc. Spray drying vancomycin
JP6152346B2 (en) 2011-03-01 2017-06-21 ジェーディーエス セラピューティックス、エルエルシーJDS Therapeutics,LLC Insulin and chromium compositions for the treatment and prevention of diabetes, hypoglycemia, and related disorders
KR102019911B1 (en) * 2011-11-02 2019-09-09 키바이오사이언스 아게 Peptide analogs for treating diseases and disorders
DK3095484T3 (en) 2011-11-02 2018-06-25 Keybioscience Ag Calcitonin mimetics for the treatment of diseases and disorders
US9533022B2 (en) * 2011-11-02 2017-01-03 KeyBioscience A/S Peptide analogs for treating diseases and disorders
WO2014028909A1 (en) 2012-08-16 2014-02-20 Ohio State Innovation Foundation Stat3 inhibitors and their anticancer use
US9750705B2 (en) 2012-08-31 2017-09-05 The Regents Of The University Of California Agents useful for treating obesity, diabetes and related disorders
CA2884707C (en) 2012-09-21 2019-03-19 Lewis Bender Method of treating cancer
CN104043104B (en) 2013-03-15 2018-07-10 浙江创新生物有限公司 The spray dried powder and its industrialized process for preparing of hydrochloric vancomycin
CA2918052A1 (en) * 2013-07-12 2015-01-15 Genentech, Inc. Elucidation of ion exchange chromatography input optimization
RS58530B1 (en) 2013-11-14 2019-04-30 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
EP3006045B1 (en) 2014-10-07 2017-04-12 Cyprumed GmbH Pharmaceutical formulations for the oral delivery of peptide or protein drugs
GB201500263D0 (en) 2015-01-08 2015-02-25 Keybioscience Ag Calcitonin analogues for treating diseases and disorders
CA2975578A1 (en) * 2015-02-09 2016-08-18 Entera Bio Ltd. Treatment of hypoparathyroidism
CA2997343A1 (en) 2015-10-07 2017-04-13 Cyprumed Gmbh Pharmaceutical formulations for the oral delivery of peptide drugs
WO2018065634A1 (en) 2016-10-07 2018-04-12 Cyprumed Gmbh Pharmaceutical compositions for the nasal delivery of peptide or protein drugs
GB201704429D0 (en) 2017-03-21 2017-05-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
GB201707955D0 (en) 2017-05-18 2017-07-05 Keybioscience Ag Dual amylin and calcitonin receptor agonists for treating diseases and disorders
UY37919A (en) * 2017-10-05 2019-03-29 Receptor Life Sciences Inc Herbal compositions with enhanced bioavailability
WO2019071213A1 (en) * 2017-10-05 2019-04-11 Receptor Life Sciences, Inc. Rapid onset and extended action plant-based and synthetic cannabinoid formulations
WO2019083904A1 (en) 2017-10-23 2019-05-02 Chan Zuckerberg Biohub, Inc. Measurement of afucosylated igg fc glycans and related treatment methods
WO2019193204A1 (en) 2018-04-06 2019-10-10 Cyprumed Gmbh Pharmaceutical compositions for the transmucosal delivery of therapeutic peptides and proteins

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES369853A1 (en) * 1969-07-24 1971-07-16 Bama S A Lab Procedure for obtaining acid derivatives ep- silon-aminocaproic.
US3795739A (en) * 1972-02-14 1974-03-05 Hoffmann La Roche Treatment of parkinson disease
US4035507A (en) * 1975-04-17 1977-07-12 Interx Research Corporation Novel, transient pro-drug forms of L-DOPA to treat Parkinson's disease
US3939253A (en) * 1973-11-02 1976-02-17 Interx Research Corporation Novel, transient pro-drug forms of l-dopa useful in the treatment of parkinson's disease
US4061466A (en) * 1974-10-16 1977-12-06 Ingvar Gosta Holger Sjoholm Biologically active composition and the use thereof
DE2500157C2 (en) * 1975-01-03 1983-09-15 Hoechst Ag, 6230 Frankfurt, De
DE2517229A1 (en) * 1975-04-18 1976-10-28 Boehringer Mannheim Gmbh Phenylalkylcarbonsaeure derivatives and process for their manufacture
DE2532420A1 (en) * 1975-07-19 1977-02-03 Boehringer Mannheim Gmbh Phenylacetic acid derivatives and process for their manufacture
CA1077842A (en) * 1975-10-09 1980-05-20 Minnesota Mining And Manufacturing Company Albumin medicament carrier system
FR2374910B1 (en) * 1976-10-23 1981-07-10 Choay Sa
NZ196349A (en) 1980-03-07 1984-08-24 Interx Research Corp Enhancement of absorption rate of orally administered polar bioactive agents
US4442090A (en) * 1980-11-09 1984-04-10 Kyoto Yakuhin Kogyo Kabushiki Kaisha Absorption-promoting compounds, compositions thereof with pharmaceuticals and/or bases for rectal administration and method of use
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
GB2092136B (en) * 1981-01-17 1985-06-05 Mitsui Toatsu Chemicals Production of n-substituted amide compounds
FR2509175B1 (en) 1981-03-06 1987-01-16 Toyo Jozo Kk A therapeutic preparation having excellent absorption properties
US4499299A (en) * 1981-12-30 1985-02-12 Ici Americas Inc. Pharmaceutically active phenylcarboxylic acid derivatives
JPH0229051B2 (en) * 1982-01-14 1990-06-27 Toyo Jozo Kk
US4654327A (en) * 1982-04-21 1987-03-31 Research Corp. Quaternary ammonium complexes of heparin
US4393192A (en) * 1982-12-21 1983-07-12 The Standard Oil Company Crystalline copolymers prepared from N,N'-terephthaloyldi-beta-alanine and a glycol
DE3331009A1 (en) * 1983-08-27 1985-03-14 Basf Ag A process for increasing the enteral absorbability of heparin and heparinoids as well as the thus obtainable heparin or heparinoidpraeparat
US4692433A (en) * 1983-10-12 1987-09-08 The Regents Of The University Of California Method and composition for regulating serum calcium levels of mammals
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
US4757066A (en) * 1984-10-15 1988-07-12 Sankyo Company Limited Composition containing a penem or carbapenem antibiotic and the use of the same
CA1234561A (en) 1985-06-26 1988-03-29 Kenneth M. White Profiled body roller-reamer stabilizer
IL77186D0 (en) 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
US4689182A (en) 1985-12-20 1987-08-25 Warner-Lambert Company Benzoic acid and benzoic acid ester derivatives having anti-inflammatory and analgesic activity
LU86258A1 (en) * 1986-01-21 1987-09-03 Rech Dermatologiques C I R D S Aromatic benzamido compounds, their method of preparing and their use in human or veterinary medicine and in cosmetics
USRE35862E (en) * 1986-08-18 1998-07-28 Emisphere Technologies, Inc. Delivery systems for pharmacological agents encapsulated with proteinoids
GB8705477D0 (en) 1987-03-09 1987-04-15 Carlton Med Prod Drug delivery systems
JPH0725725B2 (en) * 1987-07-23 1995-03-22 保土谷化学工業株式会社 Benzamide derivatives
FR2636238B1 (en) * 1988-09-14 1994-01-21 Morelle Jean News antiperspirant compositions
GB8823731D0 (en) 1988-10-10 1988-11-16 Smith Kline French Lab Biologically active compounds
FR2639395B1 (en) 1988-11-18 1991-02-15 Rockwell Cim Coupling device between a window and a mechanism of Power Windows oscillating arm in a motor vehicle
JPH02239980A (en) 1989-03-15 1990-09-21 Fuji Photo Film Co Ltd Thermal recording material
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
AU653026B2 (en) 1991-06-07 1994-09-15 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide-containing pharmaceutical composition
US5352461A (en) * 1992-03-11 1994-10-04 Pharmaceutical Discovery Corporation Self assembling diketopiperazine drug delivery system
US5714167A (en) * 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5447728A (en) * 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US6221367B1 (en) * 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US5811127A (en) * 1992-06-15 1998-09-22 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US6099856A (en) * 1992-06-15 2000-08-08 Emisphere Technologies, Inc. Active agent transport systems
HU211995B (en) 1992-06-30 1996-01-29 Gyogyszerkutato Intezet Process to prepare novel benzoyl amino acid derivs. and pharmaceutical compns. contg.them
ES2163444T3 (en) * 1993-04-22 2002-02-01 Emisphere Tech Inc Compositions and methods for the oral delivery of drugs.
US5451410A (en) * 1993-04-22 1995-09-19 Emisphere Technologies, Inc. Modified amino acids for encapsulating active agents
US5643957A (en) * 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5709861A (en) * 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
US5958457A (en) * 1993-04-22 1999-09-28 Emisphere Technologies, Inc. Compositions for the delivery of antigens
US5792451A (en) * 1994-03-02 1998-08-11 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US5541155A (en) * 1994-04-22 1996-07-30 Emisphere Technologies, Inc. Acids and acid salts and their use in delivery systems
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5989539A (en) * 1995-03-31 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
PT1093819E (en) * 1997-02-07 2006-09-29 Emisphere Tech Inc Compounds and compositions for the supply of active agents
US5650386A (en) * 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
CN1151836C (en) * 1995-03-31 2004-06-02 艾米斯菲尔技术有限公司 Compounds and compositions for delivering active agents
US5866536A (en) * 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6090958A (en) * 1995-03-31 2000-07-18 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5965121A (en) * 1995-03-31 1999-10-12 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6001347A (en) * 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5750147A (en) * 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
SI9720025A (en) * 1996-03-29 1999-08-31 Emishphere Technologies, Inc. Compounds and compositions for delivering active agents
GB2314189B (en) 1996-06-14 2000-08-09 Mars Inc Coin handling apparatus
US5804688A (en) * 1997-02-07 1998-09-08 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5776888A (en) * 1997-02-07 1998-07-07 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6313088B1 (en) * 1997-02-07 2001-11-06 Emisphere Technologies, Inc. 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
US5990166A (en) * 1997-02-07 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5879681A (en) * 1997-02-07 1999-03-09 Emisphere Technolgies Inc. Compounds and compositions for delivering active agents
US5939381A (en) * 1997-02-07 1999-08-17 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5773647A (en) * 1997-02-07 1998-06-30 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6060513A (en) * 1997-02-07 2000-05-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6051561A (en) * 1997-02-07 2000-04-18 Emisphere Technologies Inc. Compounds and compositions for delivering active agents
US5876710A (en) * 1997-02-07 1999-03-02 Emisphere Technologies Inc. Compounds and compositions for delivering active agents
US5863944A (en) * 1997-04-30 1999-01-26 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
AR017426A1 (en) * 1997-12-08 2001-09-05 Smithkline Beecham Corp Monoargininilo salt of the acid (E) -3- [1-n-butyl-5- [2- (2-carboxyphenyl) methoxy-4-chlorophenyl] -1H-pyrazol-4-yl] -2 - [(5- methoxy-2,3-dihydrobenzofuran-6-yl) methyl] -prop-2-enoic acid, pharmaceutical composition containing it, its use for the manufacture of a medicament and method for its preparation
TR200100922T2 (en) 1998-07-27 2001-09-21 Emisphere Technologies Inc. applying the lungs by way of the active ingredient.
DE69931930T2 (en) 1998-08-07 2006-10-05 Emisphere Technologies, Inc. Compounds and compositions for the administration of active substances
US6066015A (en) 1998-08-17 2000-05-23 Brown; James D. Method and system for anchoring a buoy via a screw-type anchor
AU3240900A (en) 1999-02-22 2000-09-04 Emisphere Holdings, Inc. Solid oral dosage form containing heparin or a heparinoid in combination with a carrier
DE60017888T2 (en) 1999-04-05 2006-01-19 Emisphere Technologies, Inc. Dinatrium salts, monohydrate and ethanol solvate
US7049283B2 (en) 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
ES2523857T3 (en) 2005-08-25 2014-12-02 The Arizona Board Of Regents On Behalf Of The University Of Arizona Stem cell fusion carcinogenesis model
US20070048725A1 (en) 2005-08-25 2007-03-01 Arrington Ben O'mar Machine perfusion of tissue grafts for transplantation
WO2011048589A2 (en) 2009-10-23 2011-04-28 Ben Gurion University Of The Negev Research And Development Authority Ion exchangers and methods of use thereof

Also Published As

Publication number Publication date
IL166158D0 (en) 2006-01-15
US20040106825A1 (en) 2004-06-03
JP4588221B2 (en) 2010-11-24
US20110251125A1 (en) 2011-10-13
DE60017888T2 (en) 2006-01-19
US20080269134A1 (en) 2008-10-30
EP1175390B1 (en) 2005-02-02
HK1045680A1 (en) 2005-08-12
US20020065255A1 (en) 2002-05-30
JP2002541132A (en) 2002-12-03
US20120264834A1 (en) 2012-10-18
IL166158A (en) 2010-12-30
US7384982B2 (en) 2008-06-10
US8658695B2 (en) 2014-02-25
EP1175390A1 (en) 2002-01-30
IL180118A (en) 2010-12-30
US8207227B2 (en) 2012-06-26
ES2235854T3 (en) 2005-07-16
JP4642435B2 (en) 2011-03-02
US7659311B2 (en) 2010-02-09
AU4216700A (en) 2000-10-23
CA2369591A1 (en) 2000-10-12
JP2005068161A (en) 2005-03-17
US8003697B2 (en) 2011-08-23
DE60017888D1 (en) 2005-03-10
CA2369591C (en) 2011-06-14
EP1175390A4 (en) 2002-09-04
IL180118D0 (en) 2007-06-03
IL145546A (en) 2007-10-31
US20100099621A1 (en) 2010-04-22
WO2000059863A1 (en) 2000-10-12
AT288415T (en) 2005-02-15
NZ534409A (en) 2006-03-31

Similar Documents

Publication Publication Date Title
DE60040042D1 (en) Device for delivering an intraluminal prosthesis
DK1133269T3 (en) Controlled delivery device for administration of therapeutics in the inner ear
DE60003033D1 (en) Battery powered device for delivering fragrances
HRP20010828A2 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
ZA9800078B (en) New formulation for inhalation
IL134725A (en) Air-freshener
PL196539B1 (en) Ophthalmic drug delivery device
AU3050499A (en) Drug delivery device
HK1097777A1 (en) Medicinal aerosol formulation
MXPA03008496A (en) Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier.
AT544451T (en) Pharmaceutically active isoindolin derivatives
SI1242055T1 (en) Hydrogel-driven drug dosage form
IL140306D0 (en) Microparticle formulation for inhalation
PT1473003E (en) Drug delivery device
PL365874A1 (en) Dispersions for formulating slightly or poorly soluble active ingredients
AU8127701A (en) Methods and devices for delivering a ventricular stent
AU5518198A (en) System for drug and health care supply distribution and replenishment
HK1030917A1 (en) Primary packaging unit for film-like or oblate-like administered shapes
DE69922538D1 (en) Cartridge for pollution-free delivery and administration systems
PT961612E (en) Protein stabilized pharmacologically active agents and their use
HK1005794A1 (en) Banded prolonged release active agent dosage form
NL300952I2 (en) Peramivir and pharmaceutically acceptable salts thereof
LU92681I2 (en) Nintédanib, its tautomers and its salts, in particular Nintédanib and its pharmaceutically acceptable salts, in particular Nintédanib Esilate
IL128043A (en) Multi-layered osmotic device for controlled delivery of active agents
IL127559D0 (en) Compounds and methods for providing pharmacologically active preparations and uses thereof

Legal Events

Date Code Title Description
FF Patents granted
KB Patents renewed